ADSC-derived exosomes inhibit myofibroblast transdifferentiation and attenuate airway stenosis via METTL3-mediated m6A modification of TLR2

Key Points

ADSC-derived exosomes significantly inhibit myofibroblast transdifferentiation, aiding airway repair.
Key evidence shows that upregulating METTL3 enhances m6A methylation, thereby downregulating TLR2.
Analysis reveals a novel epigenetic mechanism involving the PI3K-AKT pathway that regulates myofibroblast differentiation.
This insight may enable new therapeutic strategies for treating benign airway stenosis using targeted molecular interventions.

Abstract

ADSC-Exos promote airway repair by upregulating METTL3, which enhances m6A methylation of TLR2 mRNA, downregulates TLR2, and inhibits PI3K-AKT pathway activation, thereby inhibiting myofibroblast differentiation. This study reveals a novel epigenetic mechanism for the treatment of benign airway stenosis (BAS).

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Guoying Zhang (Thu,) studied this question.

synapsesocial.com/papers/69a7682fbadf0bb9e87e3e4d https://doi.org/https://doi.org/10.62347/xpqc7344

Bookmark

View Full Paper